The Department of Radiation Oncology and our faculty are involved with numerous active clinical trials as sponsors and collaborators. Our current active studies are listed below. If you have any questions about the particular study, please contact the study coordinator.
Feinberg Clinical Trials
Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.
Clinical Research Office
Find more about the clinical research done within the Robert H. Lurie Comprehensive Cancer Center through the Clinical Research Office.
|Gianna Mirabelli||Eric Donnelly, MD||Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery (NU UCSF14B02)|
|Gianna Mirabelli||Bharat Mittal, MD||A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920)|
|Gianna Mirabelli||Bharat Mittal, MD|
Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard0dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer (ECOG-ACRIN 3311)
|Gianna Mirabelli||Eric Donnelly, MD||A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone (ANZGOG 0902/GOG-0274/RTOG 1174)|
|Gianna Mirabelli||Eric Donnelly, MD||A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (RTOG 1304)|
|Gianna Mirabelli||Eric Donnelly, MD||Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724)|
|Gianna Mirabelli||Timothy Kruser, MD||Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance For Small Cell Lung Cancer (NRG CC003)|
|Gianna Mirabelli||Timothy Kruser, MD||Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with Or without Hippocampal Avoidance In Patients with Brain Metastases (NRG CC001)|
|Gianna Mirabelli||John Hayes, MD||A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (RTOG 0848)|
|Gianna Mirabelli||Jonathan Strauss, MD|
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer (NRG BR002)
|Gianna Mirabelli||John Hayes, MD||A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases (NRG BR001)|
|Gianna Mirabelli||Bharat Mittal, MD||Randomized Phase II And Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) (NRG HN001)|